LLY

1,045.35

-1.18%↓

JNJ

205.34

-0.12%↓

ABBV

224.4

-0.21%↓

UNH

324.92

+0.43%↑

AZN

90.2

-0.31%↓

LLY

1,045.35

-1.18%↓

JNJ

205.34

-0.12%↓

ABBV

224.4

-0.21%↓

UNH

324.92

+0.43%↑

AZN

90.2

-0.31%↓

LLY

1,045.35

-1.18%↓

JNJ

205.34

-0.12%↓

ABBV

224.4

-0.21%↓

UNH

324.92

+0.43%↑

AZN

90.2

-0.31%↓

LLY

1,045.35

-1.18%↓

JNJ

205.34

-0.12%↓

ABBV

224.4

-0.21%↓

UNH

324.92

+0.43%↑

AZN

90.2

-0.31%↓

LLY

1,045.35

-1.18%↓

JNJ

205.34

-0.12%↓

ABBV

224.4

-0.21%↓

UNH

324.92

+0.43%↑

AZN

90.2

-0.31%↓

Search

iRhythm Technologies Inc

Lezárt

SzektorEgészségügy

181.72 -0.04

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

179.62

Maximum

184.78

Fő mutatók

By Trading Economics

Bevétel

9M

-5.2M

Értékesítés

6.2M

193M

Profit margin

-2.702

Munkavállalók

2,000

EBITDA

7.7M

2.4M

Ajánlások

By TipRanks

Ajánlások

Erős vétel

12 hónapos előrejelzés

+20.6% upside

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

33M

5.9B

Előző nyitás

181.76

Előző zárás

181.72

Hangulat hírek alapján

By Acuity

34%

66%

86 / 374 Rangsor szerint Healthcare

Technikai pontszám

By Trading Central

Bizalom

Bullish Evidence

iRhythm Technologies Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2025. dec. 2. 17:29 UTC

Fő piaci mozgatók
Felvásárlások, összeolvadások, átvételek

Laurentian Bank Shares Hit Two-Year High on Plans for Break-Up, Takeover

2025. dec. 2. 16:21 UTC

Eredményjelentés

Scotiabank Aiming for Earnings Growth After Capital Markets Buoy Results in Latest Quarter -- Update

2025. dec. 2. 16:18 UTC

Eredményjelentés

Correction to Scotiabank Quarterly Earnings Buoyed Article

2025. dec. 2. 23:53 UTC

Piaci beszéd

Nikkei May Rise After Gains on Wall Street -- Market Talk

2025. dec. 2. 22:48 UTC

Eredményjelentés

Marvell's Stock Soars On Data Center Forecast -- Barrons.com

2025. dec. 2. 22:12 UTC

Piaci beszéd

Australian 3Q GDP To Show Modest Recovery In Play -- Market Talk

2025. dec. 2. 22:03 UTC

Piaci beszéd

Minerals 260's Resource Upgrade Looks Impressive -- Market Talk

2025. dec. 2. 22:00 UTC

Piaci beszéd

Global Equities Roundup: Market Talk

2025. dec. 2. 22:00 UTC

Piaci beszéd

Global Forex and Fixed Income Roundup: Market Talk

2025. dec. 2. 22:00 UTC

Piaci beszéd

Fletcher Building Loses Bull Due to Tame Housing-Market Recovery -- Market Talk

2025. dec. 2. 21:56 UTC

Eredményjelentés

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

2025. dec. 2. 21:50 UTC

Piaci beszéd

Tech, Media & Telecom Roundup: Market Talk

2025. dec. 2. 21:50 UTC

Piaci beszéd

Basic Materials Roundup: Market Talk

2025. dec. 2. 21:50 UTC

Piaci beszéd

Auto & Transport Roundup: Market Talk

2025. dec. 2. 21:44 UTC

Eredményjelentés

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

2025. dec. 2. 21:38 UTC

Piaci beszéd

Sky Network TV Has Path to Grow Dividend by 33% -- Market Talk

2025. dec. 2. 21:19 UTC

Eredményjelentés

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

2025. dec. 2. 20:06 UTC

Piaci beszéd

Oil Futures Fall Amid Russia-Ukraine Peace Talks -- Market Talk

2025. dec. 2. 19:55 UTC

Piaci beszéd

Natural Gas Futures Fall Amid Uncertain Weather Forecasts -- Market Talk

2025. dec. 2. 19:53 UTC

Piaci beszéd
Eredményjelentés

Global Equities Roundup: Market Talk

2025. dec. 2. 19:53 UTC

Piaci beszéd
Eredményjelentés

Scotiabank ROE Target Viewed as Possibly Conservative -- Market Talk

2025. dec. 2. 19:24 UTC

Piaci beszéd

Analysts Project Uptick in U.S. Ethanol Stocks -- Market Talk

2025. dec. 2. 19:06 UTC

Piaci beszéd

Precious Metals Step Back After Silver Sets Record -- Market Talk

2025. dec. 2. 18:27 UTC

Felvásárlások, összeolvadások, átvételek

Kraken to Acquire Backed Finance AG

2025. dec. 2. 17:20 UTC

Piaci beszéd

Basic Materials Roundup: Market Talk

2025. dec. 2. 17:20 UTC

Piaci beszéd

Auto & Transport Roundup: Market Talk

2025. dec. 2. 15:17 UTC

Piaci beszéd

Natural Gas Extends Gains Amid Cold Weather -- Market Talk

2025. dec. 2. 14:47 UTC

Piaci beszéd

BOE Likely to Cut Rates Further, Weakening Sterling -- Market Talk

2025. dec. 2. 14:38 UTC

Piaci beszéd

Silver Steps Back From Record Levels -- Market Talk

2025. dec. 2. 14:31 UTC

Piaci beszéd
Eredményjelentés

Scotiabank Strong Quarter Driven By Capital Markets Growth -- Market Talk

Társak összehasonlítása

Árváltozás

iRhythm Technologies Inc Előrejelzés

Célár

By TipRanks

20.6% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 220.38 USD  20.6%

Magas 244 USD

Alacsony 185 USD

14 Wall Street elemző 12 hónapos célárain alapulva a(z)iRhythm Technologies Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Erős vétel

14 ratings

12

Vétel

2

Tartás

0

Eladás

Technikai pontszám

By Trading Central

104.78 / 137.91Támogatás & ellenállás

Rövid táv

Bullish Evidence

Középtáv

Strong Bullish Evidence

Hosszú táv

Bullish Evidence

Hangulat

By Acuity

86 / 374 Rangsor szerint Egészségügy

Hangulat hírek alapján

Bullish bizonyíték

Volatilitás

Átlag alatti

Hírmennyiség (RCV)

Átlag alatti

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk iRhythm Technologies Inc

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
help-icon Live chat